MedTrace Logo

Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)

NCT06811454 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2026-01-23

No results posted yet for this study

Summary

The purpose of this study is to develop and test a new intervention to reduce depressive symptoms in post-treatment cancer participants.

Conditions

  • Depression
  • Cancer
  • Stage III Breast Cancer
  • Stage II Breast Cancer
  • Stage I Breast Cancer
  • Stage III Prostate Cancer
  • Stage II Prostate Cancer
  • Stage I Prostate Cancer
  • Stage III Colorectal Cancer
  • Stage II Colorectal Cancer
  • Stage I Colorectal Cancer

Interventions

BEHAVIORAL

MINDSET

Participants randomized to MINDSET will receive a text message at their preferred time each day for 8 weeks containing a link to the 15-minute audio content. At the end of each week (on day 7), participants will receive a second link to the weekly survey in the text. Participants will be able to play the audio content on their device by clicking the first link and access the weekly survey by clicking the second.

BEHAVIORAL

Enhanced Usual Care (EUC)

Participants will receive a 1-page brochure summarizing publicly available information on depression self-care strategies via text each week for 8 weeks on the same day they receive the text message containing a link to the weekly survey (day 7). This information will come from the Facing Forward: Life After Cancer Treatment booklet from the National Cancer Institute.38 Weekly topics will include: 1) Reducing stress; 2) Coping with stress; 3) Coping with depression; 4) Feeling angry; 5) Feeling alone; 6) Finding meaning after treatment; 7) Social relationships; and 8) Seeking support. These materials do not include any content on mindfulness or cognitive therapy.

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Chelsea Siwik, PhD · Case Comprehensive Cancer Center, Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-03
Primary Completion
2028-03-31
Completion
2029-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06811454 on ClinicalTrials.gov